1922P Targeted resequencing designed specifically for thymic epithelial tumours confirmed the high prevalence of GTF2I mutations.
Saved in:
| Title: | 1922P Targeted resequencing designed specifically for thymic epithelial tumours confirmed the high prevalence of GTF2I mutations. |
|---|---|
| Authors: | Petrini, I.1 (AUTHOR), Pardini, E.1 (AUTHOR), Cucchiara, F.1 (AUTHOR), Sardo Infirri, G.1 (AUTHOR), Burzi, I.S.1 (AUTHOR), Barachini, S.2 (AUTHOR), Monatli, M.2 (AUTHOR), Maestri, M.3 (AUTHOR), Ricciardi, R.4 (AUTHOR), Nicolì, V.1 (AUTHOR), Coppedè, F.1 (AUTHOR), Bacchin, D.5 (AUTHOR), Melfi, F.5 (AUTHOR), Aprile, V.5 (AUTHOR), Lucchi, M.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 2, Vol. 35, pS1118-S1118. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.08.2004 |
